A multicenter, open-label study to evaluate the preliminary safety and efficacy of CC-5013 [lenalidomide] in the treatment of complex regional pain syndrome (CRPS)
Phase of Trial: Phase II
Latest Information Update: 13 Feb 2008
At a glance
- Drugs Lenalidomide (Primary)
- Indications Complex regional pain syndromes
- Focus Therapeutic Use
- 13 Feb 2008 The expected completion date for this trial is now 1 Aug 2007.
- 09 Jan 2007 Status change
- 25 Oct 2005 New trial record.